ESR1 and breast cancer: Therapies that target the estrogen receptor-α (ER) have resulted in significant improvement in clinical outcomes for breast cancer patients (Early Breast Cancer Trialists’ Collaborative G 2005; Strasser-Weippl et al. 2013).